Unicycive Therapeutics UNCY
NASDAQ UNCY
$3.92 +0.05 (+1.29%)
As of: Oct 22, 2026 · 12:59 PM EDT

Unicycive Therapeutics (UNCY) Non-Current Debt (2020 - 2024)

Updated

Analysis

Unicycive Therapeutics (UNCY) Non-Current Debt (2020 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,171.37 Bn 1,139.96 Bn 19.71 Bn 47.86 Bn
2 Johnson & Johnson 645.23 Bn 565.09 Bn 17.30 Bn 35.80 Bn
3 AbbVie 502.25 Bn 475.37 Bn 12.70 Bn 62.48 Bn
4 Merck 361.34 Bn 315.71 Bn 12.21 Bn 51.08 Bn
5 Novartis Ag 302.82 Bn 266.81 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 267.91 Bn 241.60 Bn 12.86 Bn 23.68 Bn
7 Amgen 242.39 Bn 197.79 Bn 7.24 Bn 51.86 Bn
8 Gilead Sciences 193.55 Bn 167.74 Bn 6.22 Bn 23.83 Bn
9 Pfizer 172.05 Bn 118.70 Bn 10.94 Bn 60.50 Bn
10 Unicycive Therapeutics 105.52 Mn -94.46 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 -496,000.00
Dec 31, 2023 -205,000.00
Sep 30, 2023 -51,000.00
Mar 31, 2023 -240,000.00
Jun 30, 2021 88,000.00
Mar 31, 2021 1.01 Mn
Dec 31, 2020 409,000.00
API Access

Unicycive Therapeutics Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=UNCY&period=max&api_key=YOUR_API_KEY